Notice To Annual General Meeting in AlzeCure Pharma AB

About this update from Alzecure Pharma Ab

STOCKHOLM, SE / ACCESS Newswire / May 26, 2026 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB, reg. no. 559094-8302 (the "Company") are hereby invited to attend the annual general meeting to be held on Monday 29 June 2026 at 4 p.m. CET at Synch Law's premises at Birger Jarlsgatan 6, in Stockholm. REGISTRATION AND NOTIFICATIONShareholders who wish to attend the annual general meeting shall; i. be recorded in the share register maintained by Euroclear Sweden AB no later than Thursday June 18, 2026, andii. notify the Company of their intention to attend the general meeting to AlzeCure Pharma AB, Hälsovägen 7, 141 57 Huddinge, or via e-mail [email protected] no later than Tuesday June 23, 2026. Notification of attendance shall state the name, personal or corporate identity number, address and telephone number. For notification of representatives, the procedure as described applies (not more than two assistants are allowed). BROKER REGISTERED SHARESShareholders whose shares are registered in the name of a broker are, to be entitled to participate in the annual general meeting, required to have their shares registered in their own name through a broker, so that they are registered in the share register maintained by Euroclear Sweden AB on Thursday, June 18, 2026. Such registration may be temporary (so-called voting rights registration) and is requested from the broker in accordance with the broker's procedures in such time in advance as the broker determines. Voting rights registration requested by shareholders in such time that the registration has been made by the nominee no later than Tuesday 23 June, 2026, will be taken into account in the preparation of the share register. REPRESENTATIVESShareholders represented by proxy must issue a written, signed and dated power of attorney for the representative. Anyone representing a legal entity must present a registration certificate (or equivalent authorization document) showing that the persons who have signed the power of attorney are authorized signatories for the shareholder. To facilitate admission to the general meeting, shareholders are requested to send the original power of attorney and other authorization documents to AlzeCure Pharma AB, Hälsovägen 7, 141 57 Huddinge, Sweden, in connection with the notice of attendance. A proxy form is ...

View stock analysis, news, and events for Alzecure Pharma Ab